Abbott Laboratories buy UBS Group AG
Start price
23.01.25
/
50%
€113.50
Target price
23.01.26
€142.08
Performance (%)
-19.76%
End price
24.01.26
€91.07
Summary
This prediction ended on 24.01.26 with a price of €91.07. The price of Abbott Laboratories has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.76%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | 3.393% | 3.393% | -24.613% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by UBS_Group_AG for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at UBS Group AG from $146.00 to $148.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Stopped prediction by UBS_Group_AG for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€108.52
17.10.24
17.10.24
€134.85
17.10.25
17.10.25
1.35%
18.10.25
18.10.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.04
20.04.23
20.04.23
€118.42
20.04.24
20.04.24
-1.53%
21.04.24
21.04.24